Hans van Houte - Chief Financial Officer at Nurix Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Hans van Houte - trading volume in the past year for Nurix Therapeutics, Inc.

Holdings reported by Hans van Houte for Nurix Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 37.5K $911K $24.31 Oct 30, 2024 Direct Common Stock
Common Stock 33.7K $819K $24.28 Nov 1, 2024 Direct
Employee Stock Option (right to buy) 150K Feb 13, 2024 Direct Common Stock

Transactions reported by Hans van Houte for Nurix Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.